65,437 trials
Wounds
Primary: Reduction (log10) in Colony Forming Units — 0.734; -0.06 log 10 Colony Forming Units — p==0.006
Tobacco Dependence
Primary: Tonic Craving Score (QSU) Based on Self Reports — 3.53; 4.93 Scores on a scale
Leukaemia, Lymphocytic, Chronic
Primary: Number of Participants (Par.) Classified as Responders and Non-responders for Objective Response as Assessed by an Independent Endpoint Review Committee (IRC) in…
Adenoids
Primary: Severity of Nasal Obstruction Symptoms at Baseline and Week 12 as Measured by the Total Clinical Score — 3.89; 1.26 Score on a scale
Asthma
Primary: Change in Asthma Control Questionnaire (ACQ(5)) Score From Baseline at a Regional Level — -0.58 Units on a scale
Uterine Fibroids · Uterine Leiomyomata
Primary: Treatment-related Adverse Events (AE) Per Subject Resulting From HIFU Treatment of the Uterine Fibroids — 1.3 treatment-related AE/patient
Metabolism and Nutrition Disorder · Obesity
Primary: Mean Percentage Change in Fasting Body Weight From Baseline — -6.11; -0.05 percentage — p=<0.0001
Infections, Rotavirus · Rotavirus Vaccines
Primary: Number of Subjects Seroconverted for Anti-rotavirus Immunoglobulin A — 280; 5 subjects
Parkinson's Disease Dementia
Primary: Percentage of Participants With Adverse Events (AEs) Due, or Potentially Due, to Worsening of Parkinson Disease (PD) Motor Symptoms (Tremor, Muscle Rigidity…
Prostatic Hyperplasia
Primary: Number of Participants With Risk of Acute Urinary Retention and Surgery Based on an MPR Threshold of 70% — 2140; 1587; 481; 331 participants
Lumbar Disc Degenerative Disease
Primary: Overall Satisfaction Degree After 2 Weeks Treatment of Triple Therapy (MBL+MYO+NSAID). — 91.21; 7.74; 1.05; 86.4 percentage of participants
Obesity
Primary: Weight Change at 6 Months — -1.2; -0.4 percentage — p=0.31
Pancreatic Cancer
Primary: Tarceva Maximum Tolerated Dose in mg — 150 mg
Gallbladder Disease
Primary: Procedure Completion — 7 participants
Open-angle Glaucoma · Ocular Hypertension
Primary: Intraocular Pressure (IOP) for a 24-Hour Period at Week 4 — 16.8; 21.1; 23.0 Millimeters of mercury (mmHg)